Latest close: a new 52-week highSep 8, 2026what changed →2024-08-15$9.08 – $41.47 · dashed line: 200-day average2026-09-08
What is the market doing?
What the tape says about ROIV
Roivant Sciences Ltd. is +251% over the past year while the S&P 500 is +20%: 231 points ahead of the market.
+251%
1-year return · S&P 500 +20%
- vs 200-day average
- +50%
vs 200-day average · a clear uptrend
- RSI (14)
- 71
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 0.00%
Below its 52-week high
Details›
- Last close2026-09-08
- $41.47
- 1 monthS&P 500 −0.30%
- +18%
- 1 yearS&P 500 +20%
- +251%
- 5 yearsS&P 500 +85%
- +317%
- vs 50-day average$34.39
- +21%
- 52-week high
- $41.47
- 52-week low
- $11.64
- Annualised volatility
- 40%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$330M
| Year | Return |
|---|---|
| 2026 (year to date) | +91% |
| 2025 | +83% |
| 2024 | +5.3% |
| 2023 | +41% |
| 2022 | −21% |
| 2021 | −0.88% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | −7.2% |
| Feb | 6 | 2 of 6 | +5.3% |
| Mar | 6 | 0 of 6 | −8.8% |
| Apr | 6 | 5 of 6 | +2.2% |
| May | 6 | 3 of 6 | +3.5% |
| Jun | 6 | 5 of 6 | +3.5% |
| Jul | 6 | 4 of 6 | +3.3% |
| Aug | 6 | 4 of 6 | +1.1% |
| Sep | 6 | 3 of 6 | +4.4% |
| Oct | 5 | 3 of 5 | +10% |
| Nov | 5 | 4 of 5 | +2.5% |
| Dec | 5 | 4 of 5 | +23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #59 of 143 by Smart Score